Affymetrix Inc (AFFX)

14.01
0.02 0.14
NASDAQ : Technology
Prev Close 13.99
Open 14.03
Day Low/High 14.00 / 14.05
52 Wk Low/High 8.28 / 16.15
Volume 5.03M
Avg Volume 3.49M
Exchange NASDAQ
Shares Outstanding 80.54M
Market Cap 1.13B
EPS 0.13
P/E Ratio 107.61
Div & Yield N.A. (N.A)
First Week of March 22nd Options Trading For Affymetrix (AFFX)

First Week of March 22nd Options Trading For Affymetrix (AFFX)

Investors in Affymetrix, Inc. saw new options begin trading this week, for the March 22nd expiration.

Affymetrix Receives FDA Clearance Of First-of-its-kind Postnatal Test For Developmental Delays And Intellectual Disabilities In Children

Affymetrix Receives FDA Clearance Of First-of-its-kind Postnatal Test For Developmental Delays And Intellectual Disabilities In Children

Affymetrix, Inc. (NASDAQ: AFFX) today announced that it has received 510(k) clearance from the U.

University Of Bristol Collaborates With Affymetrix On Genotyping Arrays For Guaranteed Sustainability Of Wheat Production

University Of Bristol Collaborates With Affymetrix On Genotyping Arrays For Guaranteed Sustainability Of Wheat Production

Affymetrix, Inc. (NASDAQ: AFFX) and University of Bristol, Bristol, UK, announced today that they have collaboratively designed a wheat genotyping array and analyzed data from experiments as part of an effort ...

4 Tech Stocks Under $10 Moving Higher

4 Tech Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

— Affymetrix Announces Preliminary Fourth Quarter 2013 Revenue Of Approximately $91 Million —

— Affymetrix Announces Preliminary Fourth Quarter 2013 Revenue Of Approximately $91 Million —

Affymetrix, Inc., (NASDAQ: AFFX) today announced that based on preliminary, unaudited financial data, the Company expects total revenue for the fourth quarter of 2013 will be approximately $91 million, including a...

First Week of AFFX August 2014 Options Trading

First Week of AFFX August 2014 Options Trading

Investors in Affymetrix, Inc. saw new options become available this week, for the August 2014 expiration.

Short Interest Expands By 29.3% For AFFX

Short Interest Expands By 29.3% For AFFX

The most recent short interest data has been released by the NASDAQ for the 11/29/2013 settlement date, which shows a 2,182,929 share increase in total short interest for Affymetrix, Inc. , to 9,625,172, an increase of 29.33% since 11/15/2013.

4 Stocks Under $10 Moving Higher

4 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

First Week Of January 2014 Options Trading For Affymetrix (AFFX)

First Week Of January 2014 Options Trading For Affymetrix (AFFX)

Investors in Affymetrix, Inc. saw new options become available this week, for the January 2014 expiration.

New Microarray For Identifying And Subtyping Pathogenic E. Coli Using Unique DNA Signatures

New Microarray For Identifying And Subtyping Pathogenic E. Coli Using Unique DNA Signatures

Affymetrix, Inc. (NASDAQ: AFFX) announces the availability of a multi-genome pathogen microarray, designed by the Food and Drug Administration’s Center for Food Safety and Applied Nutrition (CFSAN) and built by...

Affymetrix Reports Third Quarter 2013 Operating Results

Affymetrix Reports Third Quarter 2013 Operating Results

Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the third quarter of 2013.

First Week Of AFFX December 21st Options Trading

First Week Of AFFX December 21st Options Trading

Investors in Affymetrix, Inc. saw new options begin trading this week, for the December 21st expiration.

Affymetrix Axiom® Strawberry Genotyping Array Delivers Automated Analysis For High-Resolution Genome Scanning Of Octoploid Strawberry

Affymetrix Axiom® Strawberry Genotyping Array Delivers Automated Analysis For High-Resolution Genome Scanning Of Octoploid Strawberry

Affymetrix, Inc. (NASDAQ:AFFX) announces the launch of Axiom Strawberry Genotyping Array (also called International Strawberry 90K SNP array or IStraw90), the only solution that successfully enables high-resolution...

Affymetrix To Host Conference Call On October 30th, 2013 To Announce Third Quarter 2013 Operating Results

Affymetrix To Host Conference Call On October 30th, 2013 To Announce Third Quarter 2013 Operating Results

Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will report operating results for the third quarter of 2013 after market close on Wed.

4 Stocks Under $10 Within Range of Breakouts

4 Stocks Under $10 Within Range of Breakouts

These under-$10 stocks are could be about to trigger big breakout trades.

First Week Of AFFX May 2014 Options Trading

First Week Of AFFX May 2014 Options Trading

Investors in Affymetrix, Inc. saw new options begin trading this week, for the May 2014 expiration.

Short Interest Expands By 10.4% For AFFX

Short Interest Expands By 10.4% For AFFX

The most recent short interest data has been released by the NASDAQ for the 08/30/2013 settlement date, which shows a 775,008 share increase in total short interest for Affymetrix, Inc. , to 8,194,558, an increase of 10.45% since 08/15/2013.

Affymetrix Inc. Stock Upgraded (AFFX)

Affymetrix Inc. Stock Upgraded (AFFX)

Affymetrix (Nasdaq:AFFX) has been upgraded by TheStreet Ratings from a sell to hold.

Ratings Changes Today

Upgrades: AFFX, HHS Downgrades: MBT, NXST, TRK Initiations: PANW Read on to get TheStreet Quant Ratings' detailed report:

First Week Of October 19th Options Trading For Affymetrix (AFFX)

First Week Of October 19th Options Trading For Affymetrix (AFFX)

Investors in Affymetrix, Inc. saw new options begin trading this week, for the October 19th expiration.

Affymetrix Stock Sees Short Interest Drop 15.4%

Affymetrix Stock Sees Short Interest Drop 15.4%

The most recent short interest data has been released by the NASDAQ for the 07/31/2013 settlement date, which shows a 1,572,224 share decrease in total short interest for Affymetrix, Inc. , to 8,607,056, a decrease of 15.45% since 07/15/2013.

Affymetrix Launches New OncoScan™ FFPE Assay Kit

Affymetrix Launches New OncoScan™ FFPE Assay Kit

Affymetrix, Inc. (NASDAQ: AFFX) announced the launch of the new OncoScan™ FFPE Assay Kit, a whole-genome copy number assay for highly degraded FFPE solid tumor samples, at the Cancer Cytogenomics Microarray ...

Affymetrix Reports Second Quarter 2013 Operating Results

Affymetrix Reports Second Quarter 2013 Operating Results

Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the second quarter of 2013.

Affymetrix Introduces New Axiom® 384HT Genotyping Format Enabling New Level Of Cost-Effective, High-Throughput Genotyping Studies

Affymetrix Introduces New Axiom® 384HT Genotyping Format Enabling New Level Of Cost-Effective, High-Throughput Genotyping Studies

Affymetrix, Inc. (NASDAQ: AFFX) announces the introduction of the Axiom ® 384HT genotyping format, a breakthrough cost-effective, high-throughput format for genotyping in which 384 samples are simultaneously...

Short Interest In Affymetrix Moves 11.6% Higher

Short Interest In Affymetrix Moves 11.6% Higher

The most recent short interest data has been released by the NASDAQ for the 07/15/2013 settlement date, which shows a 1,060,434 share increase in total short interest for Affymetrix, Inc. , to 10,179,280, an increase of 11.63% since 06/28/2013.

Interesting AFFX Put And Call For September 21st

Interesting AFFX Put And Call For September 21st

Investors in Affymetrix, Inc. saw new options become available this week, for the September 21st expiration.

Affymetrix To Announce Second Quarter 2013 Operating Results And Host Conference Call On July 31, 2013

Affymetrix To Announce Second Quarter 2013 Operating Results And Host Conference Call On July 31, 2013

Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will report operating results for the second quarter of 2013 after market close on Weds.

Affymetrix Inc. Stock Downgraded (AFFX)

Affymetrix Inc. Stock Downgraded (AFFX)

Affymetrix (Nasdaq:AFFX) has been downgraded by TheStreet Ratings from from a hold to sell.

Affymetrix Signs Contract With UK Biobank To Genotype 500,000 UK Individuals In The Largest Ever Study Of Genetic And Environmental Factors In Disease And Personalized Medicine

Affymetrix Signs Contract With UK Biobank To Genotype 500,000 UK Individuals In The Largest Ever Study Of Genetic And Environmental Factors In Disease And Personalized Medicine

Affymetrix, Inc. (NASDAQ: AFFX) today announced that it has signed a contract with UK Biobank to genotype 500,000 DNA samples donated by UK residents as part of a prospective epidemiological study of complex...

Aqua Gen And Center For Integrative Genomics (CIGENE) Collaborate With Affymetrix On A Salmon Genotyping Array To Achieve The World’s First High-Density View Of The Marker Patterns In The Atlantic Salmon

Aqua Gen And Center For Integrative Genomics (CIGENE) Collaborate With Affymetrix On A Salmon Genotyping Array To Achieve The World’s First High-Density View Of The Marker Patterns In The Atlantic Salmon

Aqua Gen, a member of the Erich Wesjohann (EW) Group GmBH and Center for Integrative Genomics (CIGENE) at the Norwegian University of Life Sciences (UMB) in collaboration with Affymetrix, Inc.